Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages

Nutricion Hospitalaria

Volumn 25, Issue 3, 2010, Pages 341-349

  Romeo, J ^a   Nova, E ^a   Warnberg J ^a,b   Gomez Martinez S ^a   Ligia, L E Díaz ^a   Marcos, A ^a  

^a INSTITUTO DEL FRÍO CSIC   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Fibre; Immunomodulation; Lifespan; Probiotics

Indexed keywords

BACTERIA (MICROORGANISMS);

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ADULT; AGE; AGED; CHILD; DIETARY FIBER; DRUG EFFECT; HUMAN; IMMUNOMODULATION; INFANT; REVIEW;

ADULT; AGE FACTORS; AGED; CHILD; DIETARY FIBER; HUMANS; IMMUNOMODULATION; INFANT; PREBIOTICS; PROBIOTICS; SYNBIOTICS;

EID: 77951966791     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.3.4517     Document Type: Review

References (79)

1. Gil A, Rueda R Interaction of early diet and the development of the immune system. Nutr Res Rev 2002; 15 (2): 263-92. (Pubitemid 35423607)
2. Bengmark S, Gil A. Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics. Nutr Hosp 2006; 21(2): 72-84, 73-86. (Pubitemid 43845460)
3. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009; 15 (2): 300-10.
4. Nova E, Wärnberg J, Gómez-Martínez S, Díaz LE, Romeo J, Marcos A. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr 2007; 98 (1): S90-5. (Pubitemid 47543485)
5. Wolowczuk I, Verwaerde C, Viltart O, Delanoye A, Delacre M, Pot B, Grangette C. Feeding our immune system: impact on metabolism. Clin Dev Immunol 2008; 2008: 639-803. (Pubitemid 351441837)
6. Olveira Fuster G, González-Molero I. Probiotics and prebiotics in clinical practice. Nutr Hosp 2007; 22 (2): 26-34. (Pubitemid 351947292)
7. Sia C. Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Rev Diabet Stud 2005; 2 (4): 182-6.
8. Guarner F. Hygiene, microbial diversity and immune regulation. Curr Opin Gastroenterol 2007; 23 (6): 667-72. (Pubitemid 47508798)
9. Svec P, Vásárhelyi B, Pászthy B, Körner A, Kovács L, Tulassay T, Treszl A. Do regulatory T cells contribute to Th1 skewness in obesity? Exp Clin Endocrinol Diabetes 2007; 115 (7): 439-43. (Pubitemid 47234644)
10. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF and Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34 (10): 2690-8. (Pubitemid 39430146)
11. Marschan E, Kuitunenw M, Kukkonenw K, Poussaz T, Sarnesto A, Haahtelaw V, Korpela R, Savilahti E, Vaarala O. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38: 611-18. (Pubitemid 351406072)
12. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis 2007; 25 (2): 112-7. (Pubitemid 46663776)
13. Bruzzese E, Volpicelli M, Salvini F, Bisceglia M, Lionetti P, Cinquetti M, Iacono G, Guarino A. Early administration of GOS/FOS prevents intestinal and respiratory infections in infants. J Pediatr Gastroenterol Nutr 2006; 42: 2-18.
14. Kirjavainen P, Gibson GR. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 1999; 31: 288-92. (Pubitemid 29366611)
15. Steege JC, Buurman WA, Forget PP. The neonatal development of intraepithelial and lamina propria lymphocytes in the murine small intestine. Dev Immunol 1997; 5: 1121-8.
16. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999; 69: 1046S-1051S. (Pubitemid 29205083)
17. Forchielli ML, Walker WA. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 2005; 93 (1): S41-8.
18. Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009; 87 (13): 26-34.
19. Martín R, Langa S, Reviriego C, Jimínez E, Marín ML, Xaus J, Fernández L, Rodríguez JM. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003; 143 (6): 754-8.
20. Cunningham-Rundles S. The effect of aging on mucosal host defense. J Nutr Health Aging 2004; 8 (1): 20-5. (Pubitemid 38200259)
21. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002; 50 (3): 54-9. (Pubitemid 34407457)
22. Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis 2002; 34 (2): S12-8.
23. Brück WM, Redgrave M, Tuohy KM, Lönnerdal B, Graverholt G, Hernell O, Gibson GR. Effects of bovine alpha-lactalbumin and casein glycomacropeptide-enriched infant formulae on faecal microbiota in healthy term infants. J Pediatr Gastroenterol Nutr 2006; 43 (5): 673-9. (Pubitemid 44863697)
24. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118 (2): 511-21. (Pubitemid 46085405)
25. Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 2005; 71 (5): 2318-24. (Pubitemid 40646972)
26. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008; 138: 1091-5. (Pubitemid 351769134)
27. Boehm G, Moro G. Structural and functional aspects of prebiotics used in infant nutrition. J Nutr 2008; 138: 1818S-1828S.
28. Scholtens PA, Alles MS, Bindels JG, Van der Linde EG, Tolboom JJ,Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr 2006; 42: 553-9. (Pubitemid 43804736)
29. Bakker-Zierikzee AM, Tol EA, Kroes H, Alles MS, Kok FJ, Bindels JG. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol 2006; 17: 134-40.
30. Veereman G. Pediatric applications of inulin and oligofructose. J Nutr 2007; 137 (11): 2585S-2589S. (Pubitemid 350058741)
31. Westerbeek EA, van Elburg RM, Van den Berg A, Van den Berg J, Twisk JW, Fetter WP, Lafeber HN. Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study. BMC Pediatr 2008; 8: 46.
32. Savilahti E, Kuitunen M, Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008; 8 (3): 243-8.
33. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121 (1): 116-21.
34. Ruszczynski M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 2008; 28 (1): 154-61. (Pubitemid 351782820)
35. Lee MC, Lin LH, Hung KL, Wu HY. Oral bacterial therapy promotes recovery from acute diarrhea in children. Acta Paediatr Taiwan 2001; 42: 301-5.
36. Lara-Villoslada F, Sierra S, Boza J, Xaus J, Olivares M. Beneficial effects of consumption of a dairy product containing two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714 in healthy children. Nutr Hosp 2007; 22 (4): 496-502. (Pubitemid 47344957)
37. Nova E, Toro O, Varela P, López-Vidriero I, Morandé G, Marcos A. Effects of a nutritional intervention with yogurt on lymphocyte subsets and cytokine production capacity in anorexia nervosa patients. Eur J Nutr 2006; 45 (4): 225-33. (Pubitemid 43781448)
38. Passeron T, Lacour JP, Fontas E, Ortonne JP. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006; 61 (4): 431-7. (Pubitemid 43334111)
39. Usenko DV, Gorelov AV, Bitieva RL. Use of new synbiotics in treatment of the intestinal infections among children. Vopr Pitan 2007; 76 (1): 70-5.
40. Uchida K, Takahashi T, Inoue M, Morotomi M, Otake K, Nakazawa M, Tsukamoto Y, Miki C, Kusunoki M. Immunonu-tritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int 2007; 23 (3): 243-8. (Pubitemid 46295032)
41. Schrezenmeir J, Heller K, McCue M, Llamas C, Lam W, Burow H, Kindling-Rohracker M, Fischer W, Sengespeik HC, Comer GM, Alarcon P. Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections. Clin Pediatr (Phila) 2004; 43 (3): 239-49. (Pubitemid 39090063)
42. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122 (1): 8-12.
43. Boyle R, Leonardi-Bee J, Bath-Hextall F, Tang M. Probiotics for the treatment or prevention of eczema. J Allergy Clin Immunol 2009; 123 (1): 266-7.
44. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998; 12: 491-7. (Pubitemid 28247523)
45. Marlett JA, Kajs TM, Fischer MH. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans. Am J Clin Nutr 2000; 72: 784-9.
46. Fukuda M, Kanauchi O, Araki Y, Andoh A, Mitsuyama K, Takagi K, Toyonaga A, Sata M, Fujiyama Y, Fukuoka M, Matsumoto Y, Bamba T. Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int J Mol Med 2002; 9 (1): 65-70.
47. Kanauchi O, Oshima T, Andoh A, Shioya M, Mitsuyama K. Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune system. Scand J Gastroenterol 2008; 43 (11): 1346-52.
48. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003; 92: 1335-9.
49. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ, III, Li W, Pagoto SL, Hafner AR, Ockene IS. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 2006; 83: 760-6. (Pubitemid 44713137)
50. Guarner F. Inulin and oligofructose: impact on intestinal diseases and disorders. Br J Nutr 2005; 93 (1): S61-5. (Pubitemid 43073409)
51. De Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111: 1-66.
52. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 2008; 88: 1438-46.
53. Saulnier DM, Spinler JK, Gibson GR, Versalovic J: Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 2009; 20 (2): 135-41.
54. Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, Lek P, Rezzi S, Ramadan Z, van Bladeren P, Fay LB, Kochhar S, Lindon JC, Holmes E, Nicholson JK. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol 2008; 4: 157.
55. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101 (6): 570-9.
56. Ruemmele FM, Bier D, Marteau P, Rechkemmer G, Bourdet-Sicard R, Walker WA, Goulet O. Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediatr Gastroenterol Nutr 2009; 48 (2): 126-41.
57. Pregliasco F, Anselmi G, Fonte L, Giussani F, Schieppati S, Soletti L. A new chance of preventing winter diseases by the administration of synbiotic formulations. J Clin Gastroenterol 2008; 42 (3): S224-33.
58. Steed H, Macfarlane GT, Macfarlane S. Prebiotics, synbiotics and inflammatory bowel disease. Mol Nutr Food Res 2008; 52 (8): 898-905.
59. Rayes N, Seehofer D, Neuhaus P. Prebiotics, probiotics, synbiotics in surgery-are they only trendy, truly effective or even dangerous? Langenbecks Arch Surg 2009; 394 (3): 547-55.
60. Guigoz Y, Doré J, Schiffrin EJ. The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 2008; 11 (1): 13-20. (Pubitemid 350295220)
61. Isolauri E, Kalliomäki M, Laitinen K, Salminen S. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr Pharm Des 2008; 14 (14): 1368-75. (Pubitemid 351982544)
62. Geier MS, Butler RN, Howarth GS. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 2007; 115 (1): 1-11.
63. Douglas LC, Sanders ME. Probiotics and prebiotics in dietetics practice. J Am Diet Assoc 2008; 108 (8): 1381.
64. King DE, Egan BM, Woolson RF, Mainous AG, 3rd, Al-Solaiman Y, Jesri A. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med 2007; 167: 502-6. (Pubitemid 46425664)
65. Schiffrin EJ, Thomas DR, Kumar VB, Brown C, Hager C, Van't Hof MA, Morley JE, Guigoz Y. Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging 2007; 11 (6): 475-9. (Pubitemid 350247017)
66. Ma Y, Hébert JR, Li W, Bertone-Johnson ER, Olendzki B, Pagoto SL, Tinker L, Rosal MC, Ockene IS, Ockene JK, Griffith JA, Liu S. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 2008; 24 (10): 941-9.
67. Shadid R, Haarman M, Knol J, Theis W, Beermann C, Rjosk-Dendorfer D, Schendel DJ, Koletzko BV, Krauss-Etschmann S. Effects of galactooligosaccharide and long-chain fructooligosac-charide supplementation during pregnancy on maternal and neonatal microbiota and immunity - a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 2007; 86 (5): 1426-37. (Pubitemid 350126248)
68. Bruzzese E, Volpicelli M, Squeglia V, Bruzzese D, Salvini F, Bisceglia M, Lionetti P, Cinquetti M, Iacono G, Amarri S, Guarino A. A formula containing galacto- and fructo-oligosac-charides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr 2009; 28 (2): 156-61.
69. Solis B, Nova E, Gómez S, Samartín S, Mouane N, Lemtouni A, Belaoui H, Marcos A. The effect of fermented milk on inter-feron production in malnourished children and in anorexia nervosa patients undergoing nutritional care. Eur J Clin Nutr 2002; 56 (4): 27S-33S. (Pubitemid 36163800)
70. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002; 76 (6): 1249-55. (Pubitemid 35416559)
71. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111 (2): 389-95. (Pubitemid 36228562)
72. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 2004; 114 (1): 131-6. (Pubitemid 39005129)
73. Hol J, van Leer EH, Elink Schuurman BE, de Ruiter LF, Samsom JN, Hop W, Neijens HJ, de Jongste JC, Nieuwenhuis EE. Cow's Milk Allergy Modified by Elimination and Lactobacilli study group. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol 2008; 121 (6): 1448-54.
74. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121 (4): 850-6.
75. Ivory K, Chambers SJ, Pin C, Prieto E, Arqués JL, Nicoletti C. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 2008; 38 (8): 1282-9. (Pubitemid 352019670)
76. Ogawa T, Asai Y, Tamai R, Makimura Y, Sakamoto H, Hashikawa S, Yasuda K. Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol 2006; 143 (1): 103-9.
77. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119 (1): 192-8. (Pubitemid 46037805)
78. De Preter V, Raemen H, Cloetens L, Houben E, Rutgeerts P, Verbeke K. Effect of dietary intervention with different preand probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr 2008; 62 (2): 225-31. (Pubitemid 351234257)
79. Prescott SL, Wiltschut J, Taylor A, Westcott L, Jung W, Currie H, Dunstan JA. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008; 63 (11): 1481-90.